(Research Report) “The result of the Study of the Social Economic Burden of Chronic Obstructive Pulmonary Disease (COPD)”
date : 1/16/2014

Chronic Obstructive Pulmonary Disease (COPD) is expected to become the third leading cause of death in the world in 2030 by the estimation of the World Health Organization (WHO). In Japan, the mortality rate is also expected to increase. Worsening of quality of life (QOL) is believed to have an implication on the productivity of the workers with COPD. However, we never really have a good grip of how much producitivity lost with the different degrees of COPD symtoms, nor we have a good understanding of the social economical burden of COPD in Japan. This study aims to clarify 1. The actual lost of productivity in COPD patients, 2. The affects on QOL, and 3. The prevalence of potential COPD patients.
1. QOL decreased by the level of severity.
Severity of COPD is classified as non-COPD, potential COPD, and diagnosed COPD in this study. The QOL scores of the participants showed that the QOL significantly decreased by severity of COPD. The results remained the same after adjusted with the confounding factors for age and sex.
2. The lost of time in COPD patients is significantly more than the healhty people.
The lost of time in COPD patients is 4.1 hr significantly longer than the health participants (15.8 hr vs 19.9 hr). The overtime loss due to COPD was estimated to be about 470,000 yen per person per year. Medical cost provided by the medical insurance is added up to another 60,000 yen per person per year.
3. The medical cost and production lost of COPD patients is at least 2,000 billion yen.
It is shown that the medical cost on COPD patients is 1.584 billion yen, cost of production lost is 496 billion yen, adding up to a total cost of 2.080 billion yen lost. It is believed that the total cost of lost is much more larger after incorporating the lost outside the work and the productivity lost of the potential COPD.
《Future Policy Direction》
1. Establishment of a system for early dection and treatment of COPD
Screening by simple spirometer and questionnaire is effective in the early detection of persons with suspected COPD, however it is not regularly used because it is not an essential item in the health examination. Future policy needs to establish a system for early dection and treatment of COPD, so that we can have a more effective health care screening.
2. Train more specialists to enable proper care provision system and treatment
Intervention by health professionals is essential to develop a proper care provision system and the treatment of COPD. However, there are very few respiratory specialists nor certified COPD nurses compared to other fields in Japan. With the increase demands in COPD care, it is essential to train more specialists and nurses in the relevent field.
3. Promotion of collaboration system for the relevant stakeholders
Following the example of diabetes, where the academic and medical association join hands in diabetes management through promoting dialogues and equipping medical doctors for diabetes management, COPD had also made its move in recent years such as the establishment of “Japan COPD management conference”. We expect to build a mechanism that tackles local issues through such collaboration of relevent stakeholders.
4. Promotion of populational awareness
The level of populational awareness of the word COPD is hope to increased from 25% to 80% through the promotion of Healthy Japan 21 (Second). The word of COPD needs to have a wide recognition as it helps to lead to early dection of the disease. Also, it is necessary to have a right perspective on COPD among the health care workers and relevant health sectors.
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care” (January 31, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Discussion Points] Intractable & Rare Diseases Project Discussion Paper “Intractable & Rare Diseases 2025: 10 Years After the Passing of the Intractable Diseases Act, Toward a Co-created Future” (Mar 28, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Dementia Project Information Packet for Local Government Officials “Dementia Policies for Our City: Taking the First Step in Promoting Future Measures for Dementia” (March 17, 2025)
- [Public Comment Submission] “2050 Tokyo Strategy: Making Tokyo Even Better (Draft)” (March 3, 2025)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
Featured Posts
-
2025-03-26
[Registration Open] (Webinar) The 132nd HGPI Seminar “Considering the Ideal Evidence-Based Immunization and Vaccination Policies” (April 25, 2025)
-
2025-04-02
[Registration Open] Public Event “The Patient and Citizen Lived Experience Forum 2025” (May 17, 2025)
-
2025-04-17
[Registration Open] (Webinar) The 134th HGPI Seminar “Understanding Evidence-Based Dietary Guidelines: Leveraging the Dietary Reference Intakes for Japanese” (May 28, 2025)